Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aker
Lysaker, Norway
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
01
Overview
Aker BioMarine has robust clinical and preclinical research showing krill oil’s benefit for omega-3 supplementation, with new programs using Lysoveta technology entering early-stage development for neurological and ophthalmic disorders in partnership with Medical Food Solutions Research[8][12].
- Therapeutic areas
- CardiovascularOphthalmologyEndocrinologyNeurologyMetabolic DisordersOther
- Modalities
- NutraceuticalSmall moleculeBiologic
- Industry
- Food & Nutrition
02
Partnerships
Medical Food Solutions Research (Dr. Michael Davidson – Lysoveta therapies)GEA (manufacturing/process engineering for krill protein plant)Norwegian Institute of Marine ResearchAcademic collaborations globally for krill and omega-3 studies
Beyond the preview
Go deeper on Aker.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aker.